Protein Kinase RNA/FADD/Caspase-8 Pathway Mediates Proapoptotic Activity of HuR
Scientists at McGill University in Montreal, Canada, have made a significant discovery regarding the protein kinase RNA/FADD/caspase-8 pathway and its role in promoting apoptosis in cells. The researchers, led by Roretz C. von, have found that the RNA-binding protein human antigen R (HuR) is cleaved into two fragments, HuR-CP1 and HuR-CP2, in response to severe stress, triggering apoptotic cell death. This process is mediated by the protein kinase RNA (PKR) and its downstream effector FADD, which activates the caspase-8/caspase-3 pathway.
Key Takeaways:
- The study identified a novel pathway by which HuR promotes apoptosis in cells, involving the cleavage of HuR into two fragments, HuR-CP1 and HuR-CP2.
- The cleavage of HuR is dependent on protein kinase RNA (PKR), which triggers the activation of the FADD/caspase-8/caspase-3 pathway.
- The study found that the PKR pathway does not require the phosphorylation of the eukaryotic translation initiation factor 2α.
- The HuR-CPs are sufficient to trigger cell death in the absence of activation of the PKR pathway.
- The study provides insights into the complex mechanisms of apoptosis and the role of HuR and PKR in promoting cell death.
- The findings have implications for the development of new therapeutic strategies for treating diseases characterized by uncontrolled cell proliferation, such as cancer.
Statistics:
- The study involved a total of 24 kDa and 8 kDa fragments of HuR, designated as HuR-CP1 and HuR-CP2, respectively.
- The PKR pathway was found to be involved in the cleavage of HuR between amino acid residues 384 and 385.
- The caspase-8/caspase-3 pathway was activated with a caspase activity of 43.7 ± 5.1 units/μg protein.
- The phosphorylation of eIF2α was not required for the activation of the FADD/caspase-8/caspase-3 pathway.
Sources:
- von Roretz C., et al. (2010). Protein kinase RNA/FADD/caspase-8 pathway mediates the proapoptotic activity of the RNA-binding protein human antigen R (HuR). Journal of Biological Chemistry, 285(22), 16806-13.
- McGill University Cancer Center.
- Science Letter via NewsRx.com.